Find Clinical Trials
Safety and efficacy of S 33138 versus risperidone in schizophrenic patients with predominant positive symptoms: A pilot phase IIa, international, multicentre, randomised, double-blind, parallel-group, controlled study. – CL2-33138-PO-C-RISP-160P-SCHIZOPHRENIA
Servier Protocol Code:
CL2-33138-007
Sponsor:
Institut de Recherches Internationales Servier (I.R.I.S)
EudraCT Number:
2005-000016-27
Find a recruiting site
Name:
Institut de Recherches Internationales Servier, Département des études cliniques
Phone number:
+33 1 55 72 60 00
Results
English (USA)Interventions / Treatments
The treatment(s) given to the participants in the study.
- Schizophrenia
- S033138
Other study id numbers
Other identification numbers the study may be known by.
- CL2-33138-007